Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute …
Background Clopidogrel and aspirin are the most commonly used antiplatelet therapies for
percutaneous coronary intervention (PCI). We assessed the effect of various clopidogrel and …
percutaneous coronary intervention (PCI). We assessed the effect of various clopidogrel and …
Dose comparisons of clopidogrel and aspirin in acute coronary syndromes
Current–Oasis 7 Investigators - New England Journal of Medicine, 2010 - Mass Medical Soc
Background Clopidogrel and aspirin are widely used for patients with acute coronary
syndromes and those undergoing percutaneous coronary intervention (PCI). However …
syndromes and those undergoing percutaneous coronary intervention (PCI). However …
Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study
Background Despite the use of aspirin, there is still a risk of ischaemic events after
percutaneous coronary intervention (PCI). We aimed to find out whether, in addition to …
percutaneous coronary intervention (PCI). We aimed to find out whether, in addition to …
Use of clopidogrel with or without aspirin in patients taking oral anticoagulant therapy and undergoing percutaneous coronary intervention: an open-label, randomised …
WJM Dewilde, T Oirbans, FWA Verheugt, JC Kelder… - The Lancet, 2013 - thelancet.com
Background If percutaneous coronary intervention (PCI) is required in patients taking oral
anticoagulants, antiplatelet therapy with aspirin and clopidogrel is indicated, but such triple …
anticoagulants, antiplatelet therapy with aspirin and clopidogrel is indicated, but such triple …
Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes: observations from the Clopidogrel in Unstable …
Background—We studied the benefits and risks of adding clopidogrel to different doses of
aspirin in the treatment of patients with acute coronary syndrome (ACS). Methods and …
aspirin in the treatment of patients with acute coronary syndrome (ACS). Methods and …
Early and late effects of clopidogrel in patients with acute coronary syndromes
Background—The risk of ischemic events is high, both early and late after acute coronary
syndromes (ACS). We examine the benefits and risks associated with the use of adding …
syndromes (ACS). We examine the benefits and risks associated with the use of adding …
Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events
ADK Bowry, MA Brookhart, NK Choudhry - The American journal of …, 2008 - Elsevier
Antiplatelet agents are central to the treatment and prevention of cardiovascular disease.
Although aspirin is the most widely used agent, randomized trials have assessed whether …
Although aspirin is the most widely used agent, randomized trials have assessed whether …
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial
SR Steinhubl, PB Berger, JT Mann III, ETA Fry… - Jama, 2002 - jamanetwork.com
ContextFollowing percutaneous coronary intervention (PCI), short-term clopidogrel therapy
in addition to aspirin leads to greater protection from thrombotic complications than aspirin …
in addition to aspirin leads to greater protection from thrombotic complications than aspirin …
Association of clopidogrel pretreatment with mortality, cardiovascular events, and major bleeding among patients undergoing percutaneous coronary intervention: a …
A Bellemain-Appaix, SA O'Connor, J Silvain… - Jama, 2012 - jamanetwork.com
Context Clopidogrel pretreatment is recommended for patients with acute coronary
syndromes (ACS) and stable coronary artery disease who are scheduled for percutaneous …
syndromes (ACS) and stable coronary artery disease who are scheduled for percutaneous …
Aspirin versus clopidogrel for chronic maintenance monotherapy after percutaneous coronary intervention (HOST-EXAM): an investigator-initiated, prospective …
BK Koo, J Kang, KW Park, TM Rhee, HM Yang… - The Lancet, 2021 - thelancet.com
Background Optimal antiplatelet monotherapy during the chronic maintenance period in
patients who undergo coronary stenting is unknown. We aimed to compare head to head the …
patients who undergo coronary stenting is unknown. We aimed to compare head to head the …